| Board Members | |
| Kari Shanard-Koenders, R.Ph., M.S.J. Executive Director 4001 W. Valhalla Blvd., Suite 106 Sioux Falls, SD 57106 Phone: 605-362-2737 Fax: 605-362-2738 |
Ashley Hansen, Aberdeen, SD Cheri Kraemer, Parker, SD Tom Nelson, Spearfish, SD |
The Mission of the South Dakota Board of Pharmacy is to protect and promote the health and safety of the public by supporting pharmacists and pursuing the highest quality pharmaceutical care through education, communication, licensing, legislation, regulation, and enforcement.
Stay Informed About Board Happenings - Sign up for our Listserv for the latest South Dakota Pharmacy information and updates.
BREAKING NEWS! Statewide Standing Order for Naloxone Distribution from Pharmacies in SD - click here for announcement or go to www.AvoidOpioidSD.com/pharmacy for more details.
COVID-19 RESOURCES FOR PHARMACY BOARD LICENSEES
Please read the statements below for the latest information regarding pharmacy practice and the recent outbreak of COVID-19.
Emergency Management Assistance Compact
On March 23, 2020, Governor Noem issued Executive Order 2020-07 (https://covid.sd.gov/docs/2020-07.pdf) which recognizes the licenses of medical professionals licensed in another state in accordance with the Emergency Management Assistance Compact. Pharmacists licensed in other states have the authority to practice in SD based on an active license in another state. They do not need to gain another license in SD. The Board of Pharmacy recommends that if you are utilizing the services of a pharmacist licensed in other states that you verify the licensure status of that individual. Please contact our office with any questions that you have during this Coronavirus Pandemic.
- COVID-19 Notice (PDF)
- FDA Hand Sanitizer Compounding (PDF)
- Critical Point COVID-19 Garbing (PDF)
- USP 797 Garb (PDF)
- American Association of Poison Control Centers - Use of Hydroxychloroquine (PDF)
- AMA, APHA, ASHP Issue Joint Statement About COVID-19 Medications
- Policy Statement on COVID-19 Agents – updated 4/3/2020 rescinded on June 5, 2020
- COVID-19 Pharmacy Personnel Guidance – updated 4/3/2020
- DEA Emergency Prescriptions update COVID-19 – updated 4/3/2020
- NABP FSMB Joint Statement on Inappropriate Prescribing and Dispensing of Medication During the COVID-19 Pandemic – updated 4/3/2020
- CDC - Considerations for Pharmacies during the COVID-19 Pandemic
- Updated Considerations for Pharmacies during the COVID-19 Pandemic – updated 4/16/2020
- Governor Noem's Executive Order 2020-16 suspending pharmacy and other requirements
- FDA temporary Guidance on Repackaging Propofol in COVID-19 Emergency
- Board of Pharmacy Policy Statement on Pharmacists Conducting COVID-19 Testing (updated 10/01/20)
- Advisory Opinion Prep Acts Pharmacists COVID-19 Testing
- Pharmacist Temporary Enrollment as a Clinical Diagnostic Lab from CMS
- Dexamethasone Sodium Phosphate Added to the Lists of Drugs for Temporary Compounding by Outsourcing Facilities and Pharmacy Compounders
- HHS Childhood Vaccines during COVID-19
- Pharmacists and Interns May Order and Administer COVID-19 Vaccines with Immunity under PREP Act
- Remdesivir Distribution starting 10/1/2020
- NEW! Bd Policy Statement PREP ACT Authorizations for Immunizations including Technicians
Do you know what a doctor shopper looks like? This Red Flags video from the National Association of Boards of Pharmacy helps pharmacists identify warning signs of prescription drug abuse and diversion. If the video below does not play, click here to access.